Safety of tralokinumab in atopic dermatitis
Br J Dermatol
.
2023 Mar 30;188(4):e25-e26.
doi: 10.1093/bjd/ljad007.
Author
Rosalind C Simpson
1
Affiliation
1
Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
PMID:
36702801
DOI:
10.1093/bjd/ljad007
No abstract available
MeSH terms
Antibodies, Monoclonal / adverse effects
Asthma*
Dermatitis, Atopic* / drug therapy
Humans
Severity of Illness Index
Treatment Outcome
Substances
tralokinumab
Antibodies, Monoclonal